LG
REGN icon

Leuthold Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Leuthold Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Buy
9,780
+341
+4% +$261K 0.8% 42
2025
Q4 		$7.29M Buy
9,439
+3,395
+56% +$2.31M 0.79% 46
2025
Q3 		$3.4M Buy
+6,044
New +$3.42M 0.37% 99
2023
Q3 		– Sell
-5,157
Closed -$3.71M – 212
2023
Q2 		$3.71M Sell
5,157
-188
-4% -$145K 0.48% 79
2023
Q1 		$4.39M Sell
5,345
-110
-2% -$83K 0.58% 69
2022
Q4 		$3.94M Sell
5,455
-126
-2% -$93K 0.53% 75
2022
Q3 		$3.85M Sell
5,581
-113
-2% -$71.1K 0.58% 71
2022
Q2 		$3.37M Buy
+5,694
New +$3.7M 0.48% 84
2021
Q2 		– Sell
-10,892
Closed -$5.15M – 188
2021
Q1 		$5.15M Sell
10,892
-1,034
-9% -$503K 0.65% 54
2020
Q4 		$5.76M Sell
11,926
-773
-6% -$417K 0.76% 41
2020
Q3 		$7.11M Sell
12,699
-251
-2% -$152K 0.97% 33
2020
Q2 		$8.08M Sell
12,950
-325
-2% -$184K 1.2% 22
2020
Q1 		$6.48M Sell
13,275
-1,174
-8% -$484K 1.17% 24
2019
Q4 		$5.42M Buy
+14,449
New +$4.86M 0.71% 56
2019
Q3 		– Sell
-12,281
Closed -$3.84M – 201
2019
Q2 		$3.84M Sell
12,281
-692
-5% -$230K 0.5% 85
2019
Q1 		$5.33M Buy
12,973
+4,589
+55% +$1.89M 0.72% 53
2018
Q4 		$3.13M Sell
8,384
-631
-7% -$231K 0.45% 86
2018
Q3 		$3.64M Buy
+9,015
New +$3.43M 0.4% 95

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Leuthold Group's REGN Position: Q1 2026 in Review

Leuthold Group increased its Regeneron Pharmaceuticals (REGN) stake by 3.6% in Q1 2026, buying an estimated $261K and bringing the position to 9,780 shares worth $7.56M. The position accounts for 0.8% of the portfolio, ranked #42.

Leuthold Group first reported a position in REGN in Q3 2018 and has held it in 18 quarters since. The position peaked at $8.08M in Q2 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Leuthold Group held 9,780 shares of Regeneron Pharmaceuticals worth $7.56M as of Q1 2026.
  • Leuthold Group bought 341 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $261K.
  • Regeneron Pharmaceuticals made up 0.8% of Leuthold Group's portfolio in Q1 2026, its #42 holding.
  • Leuthold Group first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 18 quarters since.
  • Leuthold Group's Regeneron Pharmaceuticals position peaked at $8.08M in Q2 2020.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.